![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
C.f.m. Co Farmaceutica Milanese Spa Milan It, based in Italy, is a pharmaceutical company.
One of their significant offerings is Promethazine hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-227 - Rev 03
This Chemical Type CEP, issued on August 25, 2015, remains in force until March 12, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 524 associated with this CEP further emphasizes